Biocartis Group Future Growth
Future criteria checks 2/6
Biocartis Group is forecast to grow revenue at 22.3% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 22.5% |
| Revenue growth rate | 22.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 10 Aug 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 100 | N/A | N/A | N/A | 1 |
| 12/31/2024 | 76 | N/A | N/A | N/A | 1 |
| 12/31/2023 | 58 | N/A | N/A | N/A | 1 |
| 6/30/2023 | 61 | -68 | -51 | -50 | N/A |
| 3/31/2023 | 59 | -67 | -49 | -47 | N/A |
| 12/31/2022 | 58 | -65 | -47 | -45 | N/A |
| 9/30/2022 | 58 | -64 | -53 | -50 | N/A |
| 6/30/2022 | 59 | -63 | -60 | -56 | N/A |
| 3/31/2022 | 57 | -67 | -64 | -61 | N/A |
| 12/31/2021 | 55 | -71 | -69 | -66 | N/A |
| 9/30/2021 | 58 | -70 | -60 | -57 | N/A |
| 6/30/2021 | 61 | -69 | -51 | -48 | N/A |
| 3/31/2021 | 58 | -66 | -47 | -44 | N/A |
| 12/31/2020 | 56 | -63 | -42 | -39 | N/A |
| 9/30/2020 | 47 | -64 | -47 | -45 | N/A |
| 6/30/2020 | 38 | -66 | -51 | -50 | N/A |
| 3/31/2020 | 38 | -65 | -54 | -52 | N/A |
| 12/31/2019 | 38 | -64 | -57 | -54 | N/A |
| 9/30/2019 | 35 | -60 | -56 | -52 | N/A |
| 6/30/2019 | 33 | -56 | -56 | -50 | N/A |
| 3/31/2019 | 31 | -52 | -52 | -46 | N/A |
| 12/31/2018 | 29 | -48 | -48 | -42 | N/A |
| 9/30/2018 | 29 | -44 | -46 | -41 | N/A |
| 6/30/2018 | 29 | -40 | -45 | -40 | N/A |
| 3/31/2018 | 26 | -41 | -45 | -40 | N/A |
| 12/31/2017 | 23 | -42 | -46 | -41 | N/A |
| 9/30/2017 | 19 | -46 | -51 | -46 | N/A |
| 6/30/2017 | 14 | -50 | -56 | -50 | N/A |
| 3/31/2017 | 14 | -50 | N/A | -52 | N/A |
| 12/31/2016 | 14 | -50 | N/A | -53 | N/A |
| 9/30/2016 | 14 | -48 | N/A | -49 | N/A |
| 6/30/2016 | 14 | -47 | N/A | -44 | N/A |
| 3/31/2016 | 15 | -43 | N/A | -36 | N/A |
| 12/31/2015 | 15 | -40 | N/A | -27 | N/A |
| 9/30/2015 | 15 | -35 | N/A | -28 | N/A |
| 6/30/2015 | 15 | -30 | N/A | -28 | N/A |
| 3/31/2015 | 13 | -29 | N/A | -32 | N/A |
| 12/31/2014 | 10 | -29 | N/A | -36 | N/A |
| 12/31/2013 | 12 | -27 | N/A | -41 | N/A |
| 12/31/2012 | 6 | -37 | N/A | -41 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 0R72's forecast earnings growth is above the savings rate (1.5%).
Earnings vs Market: Insufficient data to determine if 0R72's earnings are forecast to grow faster than the UK market
High Growth Earnings: Insufficient data to determine if 0R72's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 0R72's revenue (22.3% per year) is forecast to grow faster than the UK market (3.9% per year).
High Growth Revenue: 0R72's revenue (22.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0R72's Return on Equity is forecast to be high in 3 years time